Reduced suppressive effect of β2-adrenoceptor agonist on fibrocyte function in severe asthma

[1]  S. Erzurum,et al.  Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe Asthma , 2015, PloS one.

[2]  M. Cazzola,et al.  PDE inhibitors currently in early clinical trials for the treatment of asthma , 2014, Expert opinion on investigational drugs.

[3]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[4]  M. Trincavelli,et al.  Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. , 2013, Pulmonary pharmacology & therapeutics.

[5]  I. Adcock,et al.  p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2 Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma , 2011, Molecular Pharmacology.

[6]  A. Miller-Larsson,et al.  TGFβ-induced matrix production by bronchial fibroblasts in asthma: budesonide and formoterol effects. , 2011, Respiratory Medicine.

[7]  J. Selige,et al.  The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine‐induced proliferation and myofibroblast conversion , 2011, Journal of cellular physiology.

[8]  K. Chung,et al.  Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  C. Brightling,et al.  Fibrocyte localization to the airway smooth muscle is a feature of asthma. , 2009, The Journal of allergy and clinical immunology.

[10]  D. Aronoff,et al.  Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[11]  M. Bihl,et al.  Opposite effect of corticosteroids and long‐acting β2‐agonists on serum‐ and TGF‐β1‐induced extracellular matrix deposition by primary human lung fibroblasts , 2007 .

[12]  G. Canonica,et al.  Lung myofibroblasts as targets of salmeterol and fluticasone propionate : inhibition of α-SMA and NF-κB , 2005 .

[13]  P. Jeffery.  Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.

[14]  M. Stacey,et al.  Identification of Circulating Fibrocytes as Precursors of Bronchial Myofibroblasts in Asthma1 , 2003, The Journal of Immunology.

[15]  M. Roth,et al.  Interaction between glucocorticoids and β2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling , 2002, The Lancet.

[16]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[17]  P. Barnes,et al.  Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids , 2002, European Respiratory Journal.

[18]  K. Broadley,et al.  Chronic lipopolysaccharide exposure on airway function, cell infiltration, and nitric oxide generation in conscious guinea pigs: effect of rolipram and dexamethasone. , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[20]  O. Eickelberg,et al.  Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[21]  Malcolm W Johnson.  The β -Adrenoceptor , 1998 .

[22]  R. Bucala,et al.  Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.

[23]  F. Lembeck,et al.  Naunyn Schmiedebergs Archiv für Pharmakologie , 1969 .